Logo
HEREDITARY ANGIOEDEMA MARKET ANALYSIS
  2. / Market Insights
  3. Hereditary Angioedema Market Analysis
all report title image

HEREDITARY ANGIOEDEMA MARKET ANALYSIS

Hereditary Angioedema Market is segmented By Type (Hereditary Angioedema Type I and Hereditary Angioedema Type II), By Drug Class (C1 Esterase Inhibitor, Kallikrein Inhibitor, Bradykinin Receptor, Attenuated Androgens, and Others), By Route of Administration (Subcutaneous, Intravenous, and Oral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

  • Published In : Nov 2024
  • Code : CMI1292
  • Pages :175
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Market Concentration and Competitive Landscape

Hereditary Angioedema Market Concentration By Players

Close-monitor your Competitor's Move, Get Instant Access to the Report

Key Players Insights
    • CSL Behring
    • Sanofi
    • Takeda Pharmaceutical Company Limited
    • Orchard Therapeutics plc.
    • Pharming Group N.V.
    • BioCryst Pharmaceuticals, Inc.
    • Ionis Pharmaceuticals, Inc.
    • Attune Pharmaceuticals
    • Arrowhead Pharmaceuticals, Inc.
    • Adverum Biotechnologies, Inc.
    • KalVista Pharmaceuticals
    • CENTOGENE N.V.

    • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now

    Press Release

    Hereditary Angioedema Market to Surpass USD 5.36 Bn by 2031
    Logo

    Credibility and Certifications

    ESOMAR
    DUNS Registered
    Clutch
    DMCA Protected

    9001:2015

    Credibility and Certifications

    27001:2022

    Credibility and Certifications

    EXISTING CLIENTELE

    Joining thousands of companies around the world committed to making the Excellent Business Solutions.

    View All Our Clients
    trusted clients logo
    © 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.